Medicinal products containing diclofenac: Cardiovascular risks
2013.07.16
Active substance: diclofenac
The marketing authorisation holders of systemically acting medicinal products containing diclofenac are sending out information that new contraindications and warnings for these medicinal products have been decided following the Europe-wide evaluation of cardiovascular safety.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN